2seventy bio, Inc.
TSVT
$2.06
$0.126.19%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.03M | 36.05M | 41.62M | 56.18M | 13.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.03M | 36.05M | 41.62M | 56.18M | 13.41M |
| Cost of Revenue | 56.27M | 64.50M | 72.54M | 64.64M | 62.12M |
| Gross Profit | -44.24M | -28.45M | -30.92M | -8.46M | -48.71M |
| SG&A Expenses | 13.00M | 19.49M | 20.72M | 18.70M | 19.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.28M | 83.99M | 93.26M | 83.34M | 81.73M |
| Operating Income | -57.24M | -47.94M | -51.64M | -27.16M | -68.32M |
| Income Before Tax | -71.64M | -42.09M | -47.02M | -23.16M | -67.88M |
| Income Tax Expenses | -- | -- | -- | -17.00K | -- |
| Earnings from Continuing Operations | -71.64M | -42.09M | -47.02M | -23.14M | -67.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.64M | -42.09M | -47.02M | -23.14M | -67.88M |
| EBIT | -57.24M | -47.94M | -51.64M | -27.16M | -68.32M |
| EBITDA | -54.48M | -45.70M | -49.39M | -24.84M | -65.94M |
| EPS Basic | -1.40 | -0.83 | -1.08 | -0.60 | -1.76 |
| Normalized Basic EPS | -0.62 | -0.52 | -0.68 | -0.37 | -1.10 |
| EPS Diluted | -1.40 | -0.83 | -1.08 | -0.60 | -1.76 |
| Normalized Diluted EPS | -0.62 | -0.52 | -0.68 | -0.37 | -1.10 |
| Average Basic Shares Outstanding | 51.18M | 50.97M | 43.47M | 38.68M | 38.57M |
| Average Diluted Shares Outstanding | 51.18M | 50.97M | 43.47M | 38.68M | 38.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
